These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1958508)

  • 1. Suppression of the growth of the androgen-insensitive R3327 HI rat prostatic carcinoma by combined estrogen and antiprogestin treatment.
    Mobbs BG; Johnson IE
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):713-22. PubMed ID: 1958508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
    Mobbs BG; Johnson IE
    Cancer Res; 1988 Jun; 48(11):3077-83. PubMed ID: 3259159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in tumor characteristics during progression of the R3327 HI experimental prostatic carcinoma.
    Mobbs BG; Johnson IE
    Prostate; 1990; 16(2):127-36. PubMed ID: 1690881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative relationships between cytosol and nuclear estrogen and progesterone receptors in the R3327 prostatic carcinoma of rats treated with diethylstilbestrol.
    Mobbs BG; Johnson IE
    Prostate; 1986; 8(3):255-64. PubMed ID: 3703745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
    Thomas M; Monet JD
    J Clin Endocrinol Metab; 1992 Sep; 75(3):865-70. PubMed ID: 1517379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of RU486 on the ovarian response of immature rats to pregnant mare's serum gonadotrophin or diethylstilbestrol.
    Forcelledo ML; Leiva L; Croxatto HB
    Hum Reprod; 1994 Jan; 9(1):24-31. PubMed ID: 8195347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of androgen-insensitive human prostate carcinoma cells by a 19-norsteroid derivative agent, mifepristone.
    Lin MF; Kawachi MH; Stallcup MR; Grunberg SM; Lin FF
    Prostate; 1995 Apr; 26(4):194-204. PubMed ID: 7716084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
    Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
    J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone action in normal mouse mammary gland.
    Wang S; Counterman LJ; Haslam SZ
    Endocrinology; 1990 Nov; 127(5):2183-9. PubMed ID: 2226309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose estrogen response of the hormone independent R3327-At Copenhagen rat prostatic tumor.
    Heston WD; Lazan DW
    Cancer Lett; 1980 Nov; 11(1):57-61. PubMed ID: 7226138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptors in human decidua after RU486 treatment.
    Shi WL; Wang JD; Fu Y; Zhu PD
    Fertil Steril; 1993 Jul; 60(1):69-74. PubMed ID: 8513961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA.
    Lin VC; Ng EH; Aw SE; Tan MG; Ng EH; Chan VS; Ho GH
    Clin Cancer Res; 1999 Feb; 5(2):395-403. PubMed ID: 10037189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-classical androgenic actions of RU38486 in androgen-responsive Shionogi carcinoma 115 cells in serum-free culture.
    Lu J; Matsumoto K; Nishizawa Y; Tanaka A; Hirose T; Sato B
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):329-35. PubMed ID: 1911422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-dose estrogen on growth and steroid receptor activity in DMBA-induced mammary tumors and uteri of rats.
    Gabriel BW; Sahai G; Anderson WA
    J Toxicol Environ Health; 1983 Mar; 11(3):437-54. PubMed ID: 6341612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
    Moreno-Cuevas JE; Sirbasku DA
    In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the rat.
    Mobbs BG; Johnson IE
    J Steroid Biochem; 1985 Jan; 22(1):57-62. PubMed ID: 3871881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
    Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.